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Summary Reactive oxygen species (ROS) are critically in-
volved in the action of anticancer agents. In this study, we
investigated the role of ROS in the anticancer mechanism of
new aminoalkanol derivatives of xanthone. Most xanthones
used in the study displayed significant pro-oxidant effects
similar to those of gambogic acid, one of the most active
anticancer xanthones. The pro-oxidant activity of our xan-
thones was shown both directly (by determination of ROS
induction, effects on the levels of intracellular antioxidants,
and expression of antioxidant enzymes) and indirectly by
demonstrating that the overexpression of manganese superox-
ide dismutase decreases ROS-mediated cell senescence. We
also observed that mitochondrial dysfunction and cellular ap-
optosis enhancement correlated with xanthone-induced oxida-
tive stress. Finally, we showed that the use of the antioxidant
N-acetyl-L-cysteine partly reversed these effects of
aminoalkanol xanthones. Our results demonstrated that novel
aminoalkanol xanthones mediated their anticancer activity
primarily through ROS elevation and enhanced oxidative
stress, which led to mitochondrial cell death stimulation; this
mechanism was similar to the activity of gambogic acid.
Keywords Xanthone . Cancer . Reactive oxygen species
(ROS) . Antioxidant enzymes . Senescence
Abbreviations
CAT catalase
6-CFDA 6-carboxyfluorescein diacetate
BLEO bleomycin sulfate
DMSO (dimethyl sulfoxide)
DOX doxorubicin
FBS fetal bovine serum
GA gambogic acid
GAPDH glyceraldehyde 3-phosphate dehydrogenase
GNA gambogenic acid
GPX glutathione peroxidase
H2DCFDA 2′,7′-dichlorodihydrofluorescein diacetate
MAG α-mangostin
NAC N-acetyl-L-cysteine
PBS phosphate-buffered saline
Rh123 rhodamine 123
ROS reactive oxygen species
SOD superoxide dismutase
Introduction
Reactive oxygen species (ROS) are molecules derived from
intracellular oxygen metabolism or from the extracellular en-
vironment. Excessive ROS levels generate oxidative stress,
where oxidation of macromolecules causes significant dam-
age to cellular organelles and genes and subsequently leads to
apoptotic cell death. Multiple disorders have been associated
with oxidative stress, and oxidative stress plays a crucial role
in the progression of cancer as well as cancer treatment [1].
Redox homeostasis is maintained by the intracellular antioxi-
dant system, which consists of compounds such as reduced
glutathione, α-tocopherol or ascorbic acid that protect cellular
macromolecules from oxidative damage. However, the most
powerful element of the cellular defense system is based on
* Daniel Sypniewski
dsypniewski@sum.edu.pl
1 Department of Biotechnology and Genetic Engineering, School of
Pharmacy with the Division of Laboratory Medicine in Sosnowiec,
Medical University of Silesia, Katowice, Poland
2 Department of Bioorganic Chemistry, Chair of Organic Chemistry,
Faculty of Pharmacy, Jagiellonian University Medical College,
Krakow, Poland
Invest New Drugs (2018) 36:355–369
https://doi.org/10.1007/s10637-017-0537-x
Contribution of reactive oxygen species to the anticancer
activity of aminoalkanol derivatives of xanthone
antioxidant enzymes: superoxide dismutase (SOD), cata-
lase (CAT), and glutathione peroxidase (GPX) [2]. As
some biological systems evolved with environments rich
in ROS, ROS became an important part of cellular signal-
ing pathways. Most significantly, ROS play a key role in
the regulation of apoptosis and proliferation [1]. While
slight increases in ROS may promote cell proliferation
and differentiation [3], excess ROS levels lead to oxida-
tive damage and induction of apoptosis [4].
Cancer cells activate mechanisms to avoid ROS-
mediated apoptosis and to enhance ROS-mediated prolif-
eration and development. One such a mechanism, the
BSOD paradox^, is based on the observation that
MnSOD (mitochondrial form of SOD) expression de-
creases during neoplastic transformation, leading to accu-
mulation of superoxide anion, which in turn stimulates
cell growth via specific transcription factors [1].
However, as the tumor cells develop, MnSOD expression
significantly increases. This is accompanied by a de-
crease in CAT and GPX expression, and the overall
ROS levels constantly increase [5]. As a result, cancer
cells are under permanent oxidative stress [2, 3]. Another
important issue is the participation of ROS in the mech-
anisms of anticancer therapies. ROS mediate a significant
proportion of the anticancer effects of agents used in
chemo-, radio-, and photodynamic therapies [1, 6].
Oxidative stress is particularly enhanced by alkylating
agents and topoisomerase II inhibitors, but other drugs
(approximately 40% of chemotherapeutic agents) also ex-
hibit oxidative activity. Application of ROS-generating
agents during anticancer therapy leads to a situation
where drug-induced oxidative stress superimposes on
the intrinsic stress, which results in the preferential death
of tumor cells or inhibition of their proliferation.
Therefore, a significant mechanism of anticancer thera-
pies is based on either accumulation of ROS or inhibi-
tion of ROS neutralization. Since this Boxidation
therapy^ is a double-edged sword, some researchers have
proposed the inclusion of antioxidants as therapeutic ad-
juvants [7]. While the use of antioxidants as chemopre-
ventive agents is well established, their application in
cancer therapy is controversial. The concomitant use of
antioxidants may be beneficial not only due to their pro-
tective role in normal cells but also due to their positive
impact on chemotherapeutic efficiency. However, when
high amounts of ROS are limited through the application
of antioxidants, elimination of cancer cells by ROS may
also be blocked, mostly via inhibition of ROS-mediated
apoptosis [2].
Xanthone (9H–xanthen-9-one) is an oxygenated, heterocy-
clic compound. The large group of compounds based on the
xanthonic core are termed Bxanthone derivatives^ or simply
Bxanthones^. These compounds are natural metabolites found
primarily in higher plants [8]. Additionally, the xanthonic core
is a target of numerous structural modifications, leading to the
synthesis of new derivatives [9–12]. The natural and synthetic
xanthones together constitute a group of more than 500 com-
pounds. The structural diversity of xanthones is accompanied
by their pleiotropic biological activity, which makes them po-
tentially valuable, new therapeutic agents for the treatment of
multiple disorders. The most significant activities of xan-
thones include anticancer [10, 11, 13], antibacterial, and anti-
fungal activities [12]. Xanthones have significant effects in
cardiovascular [14] and central nervous system diseases
[15]; they also have immunomodulatory and anti-
inflammatory potential [16, 17].
Although studies reporting the anticancer properties of
xanthone derivatives have been published in recent years,
their molecular mechanisms are not fully elucidated. To date,
the most widely studied anticancer xanthones are gambogic
acid (GA), α-mangostin (MAG), and a synthetic derivative
known as 5, 6-dimethylxanthenone-4-acetic acid (DMXAA).
One of the most important factors contributing to xanthone
pleiotropy is their effect on redox balance inside the cells.
Unfortunately, reference data are often contradictory. On one
hand, biologically active xanthones have been shown to have
strong ROS-stimulating activities [18, 19]; on the other hand,
the data also show that some compounds act as antioxidants
[20]. The intensively studied GA and MAG have contrary
activities, although they both display significant antitumor
effects. While ROS-mediated signaling has great importance,
especially in cancer and cancer therapy, involvement of ROS
and oxidative stress in cells treated with xanthones have not
been sufficiently studied. Therefore, the aim of our study was
to investigate the role of ROS in the anticancer activity of new
aminoalkanol derivatives of xanthone. These compounds
were prescreened for their antiproliferative, cytotoxic, and
antimigratory effects on different cancer cell lines; the results
of this analysis have been published previously [21]. In this
study, we analyzed ROS, antioxidants, antioxidant enzymes,
mitochondrial potential and cellular senescence under xan-
thone treatment to establish the relationships between
proapoptotic potential and oxidative features of aminoalkanol
xanthone derivatives.
Materials and methods
Chemicals
DMSO (dimethyl sulfoxide), doxorubicin hydrochloride
(DOX), doxycycline hydrochloride, GA, H2DCFDA (2′,7′-
dichlorodihydrofluorescein diacetate), 30% hydrogen perox-
ide solution, MAG, N-acetyl-L-cysteine (NAC), and X-gal
were purchased from Sigma-Aldrich. Bleomycin sulfate
(BLEO) from Streptomyces verticillus was purchased from
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Euro Nippon Kayaku GMBH. Bradford Reagent was pur-
chased from Fermentas. Rhodamine 123 hydrochloride
(Rh123), as well as media and chemicals used for in vitro cell
cultivation, were purchased from ThermoFisher Scientific.
Synthesis and purification of aminoalkanol xanthone
derivatives
The detailed methodology of synthesis, purification and phys-
icochemical properties of aminoalkanol derivatives of xan-
thone have been described in our previous paper [21]. All
compounds used in the study are summarized in Table 1.
Cell culture and treatment conditions
C3H/10 T1/2 cells (mouse fibroblasts), genetically modified
mouse fibroblasts (OFF-SOD), and the human cancer cell
lines A549 and T24 were routinely propagated in suitable
media supplemented with 10% FBS and gentamicin at
37 °C in 5% CO2. OFF-SOD fibroblasts with Tet-Off-
regulated MnSOD expression were generated as described
previously [22]. Xanthones were dissolved either in water
(synthetic derivatives) or in DMSO (GA and MAG) and
stored at −20 °C. Directly before analysis, stock solutions
were diluted to obtain the working concentrations. All treat-
ments were performed under non-cytotoxic conditions. IC50
values for all xanthones were established in our previous pa-
per [21]. Treatments with all tested compounds were per-
formed for 12 h, except for hydrogen peroxide, which was
used in a 6-h treatment. Each compound was investigated in
three independent experiments; each experiment was carried
out in triplicate.
ROS detection by H2DCFDA
Intracellular ROSwere measured based on the detection of the
fluorescent product DCF (2′,7′-dichlorofluorescein) yielded
from the oxidation of H2DCFDA. Cell cultures were incubat-
ed in medium containing 10 μM of H2DCFDA for 1 h. After
the incubation medium was removed, cells were washed with
D-PBS. Stained cultures were analyzed for green fluorescence
under an inverted fluorescence microscope. In each culture
well, 10 vision fields were photographed and analyzed (at
least 100 cells in each well). The fluorescence intensity was
measured by NIS-Elements AR 3.2 software.
Total antioxidant status assay
Intracellular level of antioxidants was measured in cell ex-
tracts prepared by homogenization in assay buffer using a
commercial Antioxidant Assay Kit (Sigma-Aldrich).
Concentration of antioxidants was calculated using the
Table 1 Chemical structure of aminoalkanol xanthone derivatives evaluated in the study
No. R1 R2 R3 salt
1 -H -H x2HCl
2 -H -H x HCl
3 -H -Cl x HCl
4 -H -Cl x2HCl
5 -H -Cl xHCl
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standard curves of the absorbance values (λ = 570 nm) gen-
erated for Trolox™ dilutions.
RNA extraction
Total RNA was extracted by the phenol-chloroform method
using TRI-Reagent (Sigma-Aldrich) according to the manu-
facturer’s protocol. RNA extracts were treated with DNase I
and purified using a commercial kit (Direct-zol RNA
MiniPrep, Zymo Research) to avoid genomic DNA contami-
nation. RNA concentration was determined spectrophotomet-
rically (λ = 260 nm).
Real-time RT-PCR
Transcript levels of the studied genes, CAT, GPX, and SOD1,
were determined by SYBR Green Real-Time RT-PCR assays.
Expression of the studied genes was normalized to the endog-
enous control (GAPDHmRNA) by the ΔΔCt method with the
use of the control (untreated) cultures as calibrators. One-step
Real-Time RT-PCR assays were carried out using the
Mx3000P thermal cycler (Stratagene). Reaction mixtures
contained 12.5 μl of 2× Brilliant II SYBR Green RT-PCR
Master Mix, 1 μl of reverse transcriptase, 0.3 μM of each
sense and antisense primer, 0.1 μg of unknown RNA tem-
plate, and water to a total volume of 25 μl. All reagents were
purchased from Stratagene. The thermal profile was 50°C for
30 min (reverse transcription), 95°C for 10 min, 40 two-step
cycles of 94°C for 15 s and 58°C for 30 s, and 72°C for 10min
(real-time PCR), followed by a dissociation protocol (60–
95°C; 30min). The following oligonucleotide sequences were
used: GAPDH – sense: 5’GAA GGT GAA GGT CGG AGT
C3’; antisense: 5’GAA GAT GGT GAT GGG ATT TC3’
(amplification product: 225 bp); CAT – sense: 5’TCA GGC
AGAAACTTT TCCATT T3’; antisense: 5’TGGGTCGAA
GGC TAT CTG TT3’ (amplification product: 148 bp [23]);
GPX – sense: 5’CGG GAC TAC ACC CAG ATG AA3’;
antisense: 5’TCT CTT CGT TCT TGG CGT TC3’ (amplifi-
cation product: 115 bp [23]); SOD1 – sense: 5’GAA GGT
GTG GGG AAG CAT TA3’; antisense: 5’CCA CCG TGT
TTT CTG GATAGA3’ (amplification product: 132 bp [23]).
CAT, GPX, and SOD activities
Activities of antioxidant enzymes were determined in cell ly-
sates obtained by repeated cell freezing-thawing (2 cycles)
and homogenization in extraction buffer (pH = 7.2). Cell ly-
sates were centrifuged (600 g, 10 min), and the resulting su-
pernatants were immediately frozen at −80 °C for further anal-
yses. For GPX activity, cell lysates were prepared in the com-
mercial assay buffer provided by the manufacturer. Catalase
activity was determined by kinetic measurement (absorbance
at λ = 240 nm) of the decomposition of hydrogen peroxide
(30 mM) within 1 min. The enzyme activity was calculated as
mU/mg of protein. Protein concentration was evaluated by
Bradford assay. Activity of GPX was determined spectropho-
tometrically (λ = 340 nm) using the commercial Glutathione
Peroxidase Assay Kit (Abcam). Activity values (nM of
NADPH per 106 cells) were calculated from a standard curve
generated for NADPH standards. SOD activity was evaluated
spectrophotometrically (λ = 450 nm) by a commercial SOD
Determination Kit (Sigma-Aldrich). SOD standards were used
to obtain a standard curve for absolute activity assessment.
The enzyme activity was calculated as units per milliliter
(U/ml).
Analysis of mitochondria by Rh123 staining
Changes in mitochondrial membrane potential were estimated
by Rh123 staining according to earlier protocols [24] with
minor modifications. After the treatments, cell cultures were
washed with D-PBS and incubated in medium containing
10 μM Rh123 for 30 min. Then, cells were washed with D-
PBS and incubated for 1 h in fresh medium to allow efflux of
excess dye. After 1 h, cells were again washed with D-PBS,
and fluorescence was measured using a 492/521 nm filter.
Additionally, we analyzed Rh123-stained mitochondria mi-
croscopically to investigate their morphology followed by
xanthone treatment. Cells were seeded on sterile microscopic
coverslips incubated in culture dishes and analyzed under a
fluorescence inverted microscope using an immersion objec-
tive (magnif. 1000×). In each culture, 10 vision fields were
photographed and analyzed, which was equal to approximate-
ly 70 cells.
Apoptosis detection
Direct detection of apoptotic cells was performed by micro-
scopic analysis. Cells were washed with D-PBS and fixed
directly on culture plates for 10 min. Then, cells were stained
with annexin V Cy3 conjugate and 6-carboxyfluorescein
diacetate (6-CFDA) using a commercial kit (Sigma-Aldrich).
All analyses were carried out under an inverted fluorescence
microscope. In each culture well, 10 vision fields were
photographed and analyzed (at least 100 cells in each well).
Senescence-associated β-galactosidase activity (SA-β-gal)
For evaluation of the influence of the studied com-
pounds on cellular senescence, β-galactosidase activity
assays were performed according to Debacq-Cheniaux
et al. [25]. Cells were cultivated for 5 days. During
cultivation, the treatment with the studied compounds
was performed thrice (days: 1–3-5). After five days,
cells were washed with D-PBS, fixed, and stained with
X-gal (1 mg/ml) overnight at 37 °C. Microscopic
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analyses to evaluate the number of β–gal-positive cells
were performed with an inverted microscope. At least
300 cells were analyzed in each well.
Statistical analysis
Quantitative data were compared by Student’s t test or Mann-
Whitney U test. For multiple comparisons, ANOVA or
ANOVA Kruskal-Wallis were used; p < 0.05 was considered
significant. All calculations were performed with Statistica v.
10.0 software.
Results
Xanthones induce oxidative stress, which can be partly
reversed by NAC
Oxidative stress was evaluated by the measurement of
intracellular levels of ROS and antioxidants. ROS levels
were es t imated by measur ing the DCF (2 ′ ,7 ′ -
dichlorofluorescein) fluorescence intensity. This method
is commonly used in ROS investigations and is based
on the application of H2DCFDA (acetylated form of
DCF), which is consecutively deacetylated inside the
cells by intracellular esterases. The resulting molecule
is oxidized by intracellular ROS to produce a fluores-
cent product, DCF. Intracellular levels of antioxidants
were measured spectrophotometrically in cell extracts
using a commercial antioxidant assay kit based on the
concentration-dependent suppression of ferryl myoglobin
radicals by intracellular antioxidants. To evaluate the
relative strength of the studied xanthones we performed
the same analysis for well-established ROS inducers
(hydrogen peroxide and chemotherapeutic drugs: BLEO
and DOX) and an ROS scavenger, NAC. Statistical
analysis revealed the significant increase in ROS levels
in A549 and T24 cell cultures after treatments with our
synthetic aminoalkanol xanthones (compounds 1–4), and
with GA (the natural xanthone) (Fig. 1). The induction
of ROS was equally high for GA and compound 3, and
it was very similar to that of DOX, the strongest ROS
inducer used in the study, and exceeded the activity of
BLEO. The overall ROS levels were higher in A549
cell cultures than in T24 cultures (p = 0.008), suggest-
ing that this cell line had a higher degree of the intrin-
sic oxidative stress.
Simultaneous treatment with the studied compounds
and NAC led to significant decrease in ROS levels
(Fig. 1). NAC displayed its ROS-scavenging activity
primarily in cultures where ROS levels were significant-
ly increased by oxidative compounds, while in untreated
controls or cultures treated with MAG or compound 5,
NAC resulted in a smaller decrease in ROS levels.
Thus, we found that the antioxidant NAC partly re-
versed the oxidative activity of the studied compounds.
Analysis of the total antioxidant pools in the cellular
extracts confirmed the results of ROS examinations:
strong ROS-inducers resulted in lower concentrations
of antioxidants (Fig. 2). The most potent decrease in
antioxidant levels was generated by hydrogen peroxide.
This assay also revealed that compound 5, MAG, and
NAC contributed to the total antioxidant potential of the
treated cultures.
Xanthone-induced oxidative stress influences
the expression of CAT, GPX, and SOD
Oxidative stress induced by the xanthone treatment was
also confirmed by the increased mRNA expression of
the genes encoding antioxidant enzymes, such as CAT,
GPX, and SOD1 (Fig. 3). The most significant increase
was observed in SOD1 expression, which was enhanced
in both cell lines by all the synthetic xanthones (except
compound 5) as well as GA and reference compounds
(DOX, BLEO and hydrogen peroxide). MAG also stim-
ulated SOD1 expression but only in A549 cultures,
while the reference antioxidant NAC did not influence
SOD1 mRNA levels. CAT and GPX levels were also
affected by the xanthone treatment, and significant dif-
ferences were observed in both cell lines. Altogether,
CAT and GPX expression levels increased significantly
following treatment with all synthetic xanthones in T24
cultures, while in A549 cells, the changes in expression
were less dramatic. GA, MAG, and the reference com-
pounds similarly induced CAT and GPX mRNA levels
in both cell lines (NAC increased only GPX expression
in both cell lines). These results suggest that expression
of antioxidant enzymes at the transcriptional level is
very sensitive to treatment with anticancer agents and
that both pro- and antioxidant compounds may stimulate
their expression.
In contrast to mRNA expression, activity of the stud-
ied enzymes did not change significantly following
treatment in most cases. CAT activity in T24 cell cul-
tures was very similar in all samples except for cells
treated with MAG and compound 5, where significant
increases were observed. In A549 cell cultures, CAT
activity decreased significantly in samples treated with
compounds 2 and 3, GA, and DOX. The overall activity
of CAT was significantly higher in T24 than in A549
cells (Fig. 4). GPX activity increased significantly in
cultures treated with most compounds, and this enzyme
showed the most significant changes among all three
enzymes analyzed in our study. The highest enhance-
ment was observed for compounds 2 and 4, GA,
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DOX, and BLEO compared to the control cultures
(Fig. 4). Total SOD activity measurements revealed that
statistically significant changes were observed only in
cultures treated with the natural xanthones: MAG (only
in T24), GA, and DOX, as well as T24 cultures treated
with hydrogen peroxide, where the highest increase was
observed (Fig. 4). As in other assays, MAG and GA
exerted completely opposite effects, leading to signifi-
cant increases and decreases in SOD activity, respective-
ly. These results indicate that MAG was the only com-
pound in the analysis that significantly contributed to
the improvement of the antioxidant cellular defense
system, while the strongest oxidative compounds, GA,
and DOX, led to significant depletion of cellular pools
of active SOD.
Mitochondrial dysfunction and apoptosis enhancement
correspond with xanthone-induced oxidative stress
To investigate the influence of xanthone treatment on cel-
lular mitochondria, we analyzed mitochondrial morphology
and transmembrane potential utilizing Rh123 staining.
Fig. 5a and b present the results of Rh123 fluorescence
measurement in cell cultures subjected to treatment with
Fig. 1 Results of ROS detection
by H2DCFDA in A549 (a) and
T24 (b) cell cultures. NAC was
used in each analysis as the
control antioxidant. For each
culture, 10 vision fields of three
independent experiments were
captured and analyzed. Mean
value (+/− stand. Dev.) of the
fluorescence (summary intensity)
was measured by NIS-Elements
AR 3.2 software. * depicts statis-
tically significant difference vs.
untreated controls (p < 0.05)
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the studied compounds. These results indicate that all
compounds displaying oxidative properties (compounds
1–4, GA, DOX, BLEO, and hydrogen peroxide) decreased
the Rh123 green fluorescence values. Depolarization of the
mitochondrial membrane is manifested by the loss of
Rh123 by mitochondria. The dye is then removed by cel-
lular membrane transporters, which leads to the decrease
in intracellular fluorescence intensity. Oxidative stress re-
sults in mitochondrial membrane permeabilization.
Therefore, Rh123, which normally penetrates mitochondri-
al membranes, leading to their bright green fluorescence,
loses its affinity to mitochondria. The Rh123-stained cells
were also examined microscopically to assess the symp-
toms of mitochondrial dysfunction (Table 2). According to
a previous study [26], the appearance of swollen mito-
chondria or megamitochondria, which are enlarged struc-
tures (approximately three times bigger than the normal
mitochondria), is a morphological symptom of mitochon-
drial deterioration. Although mitochondrial morphology
was estimated qualitatively, treatment with compounds
displaying oxidative potential affected the mitochondrial
morphology (Fig. 5c).
Since mitochondrial dysfunction is an early symptom
of apoptosis, we further examined if our studied com-
pounds efficiently induced ROS-mediated cell death
using microscopic evaluation of apoptotic, necrotic,
and viable cells in the cultures. All compounds used
in the study efficiently enhanced apoptosis, as indicated
by the elevated number of apoptotic cells in drug-
treated cultures. Importantly, MAG and compound 5 al-
so induced apoptosis despite their antioxidant properties.
Addition of the antioxidant NAC restored the mitochon-
drial potential in cell cultures treated with oxidative
compounds, such as synthetic xanthones 1–4, GA, and
standard compounds (DOX, BLEO, and hydrogen per-
oxide) (Fig. 5a and b); it also decreased the number of
dead cells (Fig. 6). In contrast, NAC did not significant-
ly influence apoptosis induced by MAG or compound 5,
and these compounds did not impair mitochondrial ac-
tivity (Fig. 5). Altogether, these results suggest that cell
death is efficiently induced by all the xanthones ana-
lyzed in our study, including the antioxidant MAG and
compound 5. Although apoptosis was enhanced to a
similar degree by antioxidant and pro-oxidant com-
pounds, a difference was observed when NAC was
added: it significantly decreased cell death induction
only in cultures treated with pro-oxidant compounds.
Thus, our results indicate that there is a relationship
among ROS stimulation by oxidative xanthones (GA
and four aminoalkanol derivatives), mitochondrial im-
pairment, and their pro-apoptotic activities. Addition of
NAC reversed the oxidative activity and subsequently
led to a decrease in the pro-apoptotic potential only
for those compounds that induced oxidative stress in
cancer cells.
Overexpression of MnSOD diminishes xanthone-induced
senescence of fibroblasts
To further elucidate the role of oxygen stress in medi-
ating xanthone activity, we examined an in vitro model
of tetracycline-regulated overexpression of an antioxi-
dant enzyme, MnSOD. In this model, we used the
OFF-SOD fibroblasts, which overexpress MnSOD under
normal conditions. Thus, we established that our studied
xanthones induce cellular senescence, and more impor-
tantly, we demonstrated that this change was related to
the induction of oxidative stress. The results presented
Fig. 2 Total antioxidant
concentrations in cell lysates of
A549 and T24 cultures treated
with the studied compounds.
Concentration of antioxidants
were calculated using the
standard curves of the absorbance
values of standards (Trolox
dilutions). NAC was used in each
analysis as the control
antioxidant. Graph presents the
mean value (+/− stand. Dev.) of
three independent experiments,
each in triplicate. * depicts
statistically significant differences
vs. untreated controls (p < 0.05)
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in Fig. 7 indicate that overexpression of MnSOD itself
protects fibroblasts from the deleterious influence of
ROS: β-galactosidase activity was significantly lower
in the control (untreated) cultures of OFF-SOD com-
pared to normal (p = 0.013) or doxycycline-modulated
(p = 0.003) cultures. MnSOD also prevented drug-
induced senescence in cultures treated with the studied
compounds. Only cell cultures treated with compound 3,
GA, DOX, and hydrogen peroxide showed a statistically
significant increase in β-galactosidase activity. In con-
trast, normal fibroblast cultures or cultures induced with
doxycycline showed increased senescence after the treat-
ment with compounds 1–4, GA, and the control ROS
inducers (DOX, BLEO, and hydrogen peroxide). These
results indicate that the studied xanthones (GA and
compounds 1–4) induce oxidative stress, which leads
to cellular senescence. For GA, the activity is so strong
that even overexpression of MnSOD cannot eliminate its
effect on senescence, which is comparable only to the
strongest ROS inducers used in our study: DOX and
hydrogen peroxide.
Discussion
Xanthone derivatives constitute a group of over 500
compounds, which includes numerous compounds with
promising anticancer properties. To date, two xanthones,
GA and DMXAA, have been qualified in clinical trials
[27, 28], and preclinical investigations on many others
are being carried out. Elucidation of the molecular
mechanism by which xanthones exert their anticancer
Fig. 3 Relative mRNA levels of
the genes encoding antioxidant
enzymes in A549 (a) and T24 (b)
cancer cell cultures treated with
the studied compounds (mean +/−
stand. Dev.). mRNA levels of
each gene were measured by real-
time RT-PCR. Relative expres-
sion was calculated by the ΔΔCt
method and expressed as the
mean fold change of mRNA ex-
pression compared to a calibrator
(untreated control). * depicts sta-
tistically significant differences
vs. untreated controls (p < 0.05)
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activity is necessary for further rational screening and
synthesis of new derivatives. According to a previous
study, the major mechanisms of anticancer activity of
xanthones resemble those mechanisms displayed by oth-
er well-established chemotherapeutic agents, which pri-
ma r i l y i n c l ude d i r e c t i n t e r a c t i on w i t h DNA
(intercalation, alkylation, cross-linking) and inhibition
of topoisomerases [10, 13]. In our previous study, we
demonstrated that newly synthesized aminoalkanol xan-
thone derivatives showed cytotoxic activity and im-
paired cancer cell motility [21]. In this study, we ana-
lyzed the involvement of ROS in the mechanism of
anticancer activity of these aminoalkanol xanthones.
We compared our compounds with the natural xan-
thones GA and MAG. Since both of them showed sig-
nificant antitumor activity, despite their contradictory
influence on redox state in cancer cells, we investigated
to what extent the involvement of oxidative stress dic-
tates the efficiency of anticancer xanthones. Several an-
ticancer compounds have been shown to stimulate oxi-
dative stress, which contributes to their anticancer
mechanism of action. This group includes anthracyclines
(e.g., DOX), most alkylating agents and platinum deriv-
atives, bleomycin, mitomycin C, or etoposide. For DOX
and BLEO, oxidative stress is an important element of
their activity. In the case of xanthones, previous studies
have demonstrated that the most active anticancer deriv-
atives act by utilizing oxidative stress [11, 17–19,
29–32]. The results of our present study suggest that
most of our synthetic xanthones stimulate oxidative
stress in the studied cell cultures. Treatment of A549
and T24 cells with the studied compounds led to
Fig. 4 Activity of the antioxidant
enzymes measured in cell lysates
of A549 (a) and T24 (b) cultures
(mean +/− stand. Dev.). All
measurements were performed
using spectrophotometric
methods described in the
Materials and Methods section.
Graph presents the mean value
(+/− stand. Dev.) of fold change
compared to control (untreated)
cultures. * depicts statistically
significant differences vs. un-
treated controls (p < 0.05)
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significant increases in ROS, decreases in total antioxi-
dant levels, and enhanced expression of antioxidant en-
zymes at the mRNA level. Oxidative stress induced by
these compounds led to mitochondria dysfunction,
which correlated with cell death enhancement. It also
induced ROS-associated senescence, and overexpression
of MnSOD reversed this process. We included in our
analysis two natural xanthones, GA and MAG, which
are the most extensively investigated anticancer xan-
thone derivatives. Moreover, they have completely op-
posite modes of action: GA strongly induces oxidative
stress, which is important if not crucial for its anticancer
properties [19, 33], while MAG has been demonstrated
by numerous studies to be an antioxidant despite its
significant anticancer activity. Our results supported
those reports. These data, both from previous studies
and our analysis, clearly demonstrate that the xanthonic
core, which gives rise to a few hundred natural or syn-
thetic derivatives, does not determine xanthone’s activi-
ty. Instead, the nature and localization of side substitu-
ents dictates the overall biological features of a specific
xanthone derivative.
The literature indicates that most anticancer xan-
thones stimulate ROS, and this significantly contributes
Fig. 5 Evaluation of mitochondria using Rh123 staining. Results of
Rh123 fluorescence measurements (mean +/− stand. Dev.) in A549 (a)
and T24 (b) cells indicating the loss of mitochondrial membrane potential
under xanthone treatment. * depicts statistically significant differences vs.
untreated controls (p < 0.05). NAC was used in each analysis as the
control antioxidant. c Representative images of A549 and T24 cells
stained with Rh123. The symptoms of mitochondrial swelling can be
observed as an increase in size (<3 times), and megamitochondria are
the large structures (increased by more than thrice), which are usually
accompanied by an overall decrease in Rh123 fluorescence and
diffusion of Rh123 to the cytoplasm indicating the general deterioration
of mitochondrial function
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to their mode of action. One of the most studied xan-
thones, GA, has been shown to stimulate ROS in many
cancer cell lines [19, 33]. Moreover, GA-mediated ROS
generation is responsible for enhancement of apoptosis,
and the addition of antioxidants diminished the antican-
cer activity of GA. Nie et al. confirmed that ROS ac-
cumulation generated by GA contributed to mitochon-
drial damage, which manifested as the loss of trans-
membrane potential and subsequently the induction of
the mitochondrial pathway of apoptosis; NAC addition
partly reversed the anticancer activity of GA [19].
Similar observations were confirmed for other, less ex-
tensively studied xanthones, either natural or synthetic
[29], such as GA-analogues (GNA, cluvenone) [18, 32],
EPOX [34], 1-hydroxyl-3-aminoalkoxy derivatives [11]
or griffipavixanthone [30]. Finally, ROS have been
shown to be the chief mediators of DMXAA activity
as an inducer of cytokine secretion, which is an impor-
tant molecular mechanism of the indirect anticancer and
immune modulatory actions of this compound [17].
Fig. 5 (continued)
Table 2 Qualitative results of microscopic evaluation of mitochondrial
impairment inA549 andT24 cell cultures treatedwith the studied compounds
Swollen mitochondria Megamitochondria
- NAC + NAC - NAC + NAC
Untreated – – – –
Comp. 1 + – – –
Comp. 2 ++ – + –
Comp. 3 ++ + ++ +
Comp. 4 + – + –
Comp. 5 – – – –
Comp. 5 + H2O2 + X + X
MAG – – – –
MAG + H2O2 + X + X
GA +++ ++ +++ +
DOX +++ ++ +++ ++
BLEO ++ – + –
Hydrogen peroxide ++ + +++ ++
NAC was used in each analysis as the control antioxidant. Mitochondria
were stained with Rh123 and analyzed under a fluorescence microscope
(magnif. 1000×). For each culture, 10 visual fields of three independent
experiments were captured and analyzed. Representative images are pre-
sented in Fig. 5a
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In our study, we also analyzed the expression and
activity of the antioxidant enzymes CAT, GPX, and
SOD. While the mRNA expression of all three genes
significantly increased in most cultures treated with xan-
thones, their enzymatic activities were not always
changed: the highest changes were observed in cultures
treated with the most pro-oxidant compounds. Previous
data indicate that therapies based on oxidative agents
decrease the activity of antioxidant enzymes due to their
consumption in ROS-scavenging reactions [35]. An in-
crease in ROS levels is a signal to enhance the expres-
sion of antioxidant enzymes; however, high levels of
ROS lead to the depletion of active enzyme pools, and
thus, decreased activity may be observed, although their
expression is enhanced. Similar observations have been
published in other studies analyzing MAG [36, 37] or
natural xanthones from Swertia chirayita [38]. Other
xanthones lack suitable data.
Although most xanthone derivatives described in the ref-
erences have pro-oxidant features, MAG, one of the most
active natural xanthones, as well as other natural xanthones
from mangosteen (Garcinia mangostana) fruit, have been
shown to display antioxidant properties [20, 31, 36, 37,
39]. MAG treatment leads to a dose-dependent inhibition
of hypoxia-induced migration of pancreatic cancer cells by
diminishing the elevated levels of ROS as efficiently as
NAC [40]. Antioxidants such as MAG may serve as adju-
vants in therapies utilizing strong pro-oxidant agents to
exert cytoprotective activity toward the normal cells in hyp-
oxic conditions where high levels of ROS are observed
Fig. 6 Results of microscopic
evaluation of apoptosis and
necrosis in A549 (a) and T24 (b)
cell cultures using double staining
with annexin V Cy 3-conjugate
and 6-CFDA. Viable cells were
stained green, cells in the early
stages of apoptosis were stained
both red and green, and necrotic/
dead cells were stained red only.
Each column represents distribu-
tion of apoptotic, necrotic, and
live cell pools (the mean of three
independent experiments). NAC
was used in each analysis as the
control antioxidant
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[41]. However, MAG and other mangosteen extract com-
ponents have also been shown to stimulate apoptosis in
various cancer cell lines, and this effect has been linked
with their capacity to induce ROS and destabilize mito-
chondria (loss of transmembrane potential, swelling, cyto-
chrome c release) [42–44]. Sun et al. reported that MAG
scavenged hydroxyl radicals, superoxide anions, and hydro-
gen peroxide but increased the levels of singlet oxygen,
which leads to apoptosis [31]. Overall, these studies dem-
onstrate two important discoveries: first, whether these nat-
ural xanthones serve as antioxidants or apoptosis inducers
depends on the concentration used. Second, the key role of
singlet oxygen in apoptosis induction has been demonstrat-
ed, which links MAG and other antioxidant xanthones with
their potential use as anticancer agents either alone or in
combination with other chemotherapeutic drugs.
Our study focused on verification of novel synthetic
xanthone derivatives and their molecular mechanisms
involving ROS signaling. We demonstrated that our
aminoalkanol xanthone derivatives promoted oxidative
stress and thereby induced the death of cancer cells.
Thus, we concluded that the mechanism of action of
our xanthones is similar to that exerted by GA, one of
the most active anticancer xanthones and a potent ROS
inducer. The group of analyzed xanthones included de-
rivatives with different side chains, which was reflected
by the different degree of ROS stimulation displayed by
these compounds; nevertheless, most of them signifi-
cantly induced oxidative stress in cancer cell cultures.
We showed that ROS constitute an important element of
the proapoptotic activity of aminoalkanol xanthones, es-
pecially compounds 3 and 4, which even exceeded the
oxidative potential of GA in some assays used in the
study. Data from previous studies indicate that even the
antioxidant MAG mediates its cytotoxic activity in can-
cer cultures through ROS; thus, based on our results
and other studies, we conclude that pro-oxidants should
be screened for potential use in anticancer therapy.
Fig. 7 Senescence-induced β-
galactosidase expression in ge-
netically modified (OFF-SOD)
and normal fibroblasts (C3H/
10 T1/2) submitted to drug-
induced senescence with the
studied compounds. The OFF-
SOD with tetracycline-regulated
overexpression of MnSOD (Tet-
Off system) cell line was
established as described in the
Materials and Methods section. a
Representative images of cell
cultures stained for β-
galactosidase activity (magnif.
200×). Cells expressing endoge-
nous β-galactosidase were
stained blue-green, while non-
expressing cells remained un-
stained. b Quantitative results of
microscopic evaluation (mean
+/− stand. Dev.). * depicts statis-
tically significant difference vs.
untreated controls (p < 0.05)
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